Kitty has 20 years of business advisory & industry experience across Asia, US & Europe; >10 years in APAC healthcare

Relevant achievements:

• Assessment of value-based care & financing models for a healthcare cluster and tech enablers (SG)
• New outpatient care and digital care delivery models & opportunities in local markets (SG)
• Support for a health & promotion regulator for wellness digital launch between a global tech company (SG)
• Next generation senior care models & opportunities in digital and technology for transformation (SG)
• Future of primary care & opportunity for value (SG)
• Developed 5-year digital product strategy and customer experience for a govt agency focused on innovation and tech enablement (SG)
• Developed a 5-year MedTech strategy, target operating model and implementation roadmap for a public sector agency that spearheads scientific research & technological innovation (SG)
• Assessment & validation of value-based care approaches & relevance to local ecosystem for the largest global MedTech company (SG)
• Post-transaction value-creation & transformation for a regional enablement & outpatient care platform (HQ'd in SG)
• Operational due diligence of one of the largest health payors /providers in SEA
• Health tech investment scan & opportunity in China, in a post-COVID world, incl. digital health
• Integration support for a regional enablement & outpatient provider
• Previously, Kitty was a Director in Corporate Development for Zuellig Pharma where she was responsible for strategic support across markets and developing innovations.

Kitty holds an MBA from London Business School and BBA from University of Michigan (Ann Arbor)